Zabinski RF - Search Results

1

Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity.

Doronina SO, Mendelsohn BA, Bovee TD, Cerveny CG, Alley SC, Meyer DL, Oflazoglu E, Toki BE, Sanderson RJ, Zabinski RF, Wahl AF, Senter PD. Doronina SO, et al. Among authors: zabinski rf. Bioconjug Chem. 2006 Jan-Feb;17(1):114-24. doi: 10.1021/bc0502917. Bioconjug Chem. 2006. PMID: 16417259

2

Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate.

Hamblett KJ, Senter PD, Chace DF, Sun MM, Lenox J, Cerveny CG, Kissler KM, Bernhardt SX, Kopcha AK, Zabinski RF, Meyer DL, Francisco JA. Hamblett KJ, et al. Among authors: zabinski rf. Clin Cancer Res. 2004 Oct 15;10(20):7063-70. doi: 10.1158/1078-0432.CCR-04-0789. Clin Cancer Res. 2004. PMID: 15501986

3

Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates.

Sutherland MS, Sanderson RJ, Gordon KA, Andreyka J, Cerveny CG, Yu C, Lewis TS, Meyer DL, Zabinski RF, Doronina SO, Senter PD, Law CL, Wahl AF. Sutherland MS, et al. Among authors: zabinski rf. J Biol Chem. 2006 Apr 14;281(15):10540-7. doi: 10.1074/jbc.M510026200. Epub 2006 Feb 16. J Biol Chem. 2006. PMID: 16484228 Free article.

4

Antibody targeting of B-cell maturation antigen on malignant plasma cells.

Ryan MC, Hering M, Peckham D, McDonagh CF, Brown L, Kim KM, Meyer DL, Zabinski RF, Grewal IS, Carter PJ. Ryan MC, et al. Among authors: zabinski rf. Mol Cancer Ther. 2007 Nov;6(11):3009-18. doi: 10.1158/1535-7163.MCT-07-0464. Mol Cancer Ther. 2007. PMID: 18025285

5

Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.

Temming K, Meyer DL, Zabinski R, Dijkers EC, Poelstra K, Molema G, Kok RJ. Temming K, et al. Bioconjug Chem. 2006 Nov-Dec;17(6):1385-94. doi: 10.1021/bc060087z. Bioconjug Chem. 2006. PMID: 17105215

6

Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative.

Temming K, Meyer DL, Zabinski R, Senter PD, Poelstra K, Molema G, Kok RJ. Temming K, et al. Mol Pharm. 2007 Sep-Oct;4(5):686-94. doi: 10.1021/mp0700312. Epub 2007 Aug 8. Mol Pharm. 2007. PMID: 17683157

7

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers.

Smith LM, Nesterova A, Ryan MC, Duniho S, Jonas M, Anderson M, Zabinski RF, Sutherland MK, Gerber HP, Van Orden KL, Moore PA, Ruben SM, Carter PJ. Smith LM, et al. Among authors: zabinski rf. Br J Cancer. 2008 Jul 8;99(1):100-9. doi: 10.1038/sj.bjc.6604437. Epub 2008 Jun 10. Br J Cancer. 2008. PMID: 18542072 Free PMC article.

8

Metal ion inhibition of nonenzymatic pyridoxal phosphate catalyzed decarboxylation and transamination.

Zabinski RF, Toney MD. Zabinski RF, et al. J Am Chem Soc. 2001 Jan 17;123(2):193-8. doi: 10.1021/ja0026354. J Am Chem Soc. 2001. PMID: 11456503

9

Reactions of alternate substrates demonstrate stereoelectronic control of reactivity in dialkylglycine decarboxylase.

Sun S, Zabinski RF, Toney MD. Sun S, et al. Among authors: zabinski rf. Biochemistry. 1998 Mar 17;37(11):3865-75. doi: 10.1021/bi972055s. Biochemistry. 1998. PMID: 9521707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters